Frost & Sullivan Releases White Paper on Healthcare Intelligence Industry: Yidu Tech Leads China’s Healthcare Intelligence Market

Frost & Sullivan, an internationally renowned research & consulting firm, has recently released a white paper on the healthcare intelligence industry (hereafter referred to as the “White Paper”). The White Paper comprehensively defines the healthcare intelligence industry by five essential elements, namely big data, cloud computing, artificial intelligence (“AI”) technology capability, medical knowledge, and scenario-based experience, as well as the high-frequency iteration of scenarios and algorithms. According to the White Paper, China’s healthcare intelligence market is expected to exceed RMB1.1 trillion in 2030.

In addition, the White Paper pointed out that Yidu Tech Inc. (hereafter referred to as "Yidu Tech" or the "Company”, HKEx: 2158), a leading company in the healthcare intelligence industry, has the largest market share in “China’s healthcare intelligence market”, the “medical institutions & regulatory agencies healthcare intelligence market” and “China’s emerging healthcare intelligence market”, reflecting its recognition of the Company's leadership in the continuous development of the industry.

Backed by favourable policies, the healthcare intelligence market is expected to exceed RMB1 trillion

In recent years, national policies continue to promote the integration of the healthcare industry with cutting-edge technologies. The 14th Five-Year Plan specifies that China will continue to strive for breakthroughs in natural language processing and other AI fields. In addition, the "Healthy China 2030" Planning Outline also proposes to continuously drive the integration of big data technology into the healthcare industry and accelerate the application of AI technology in the field including clinical auxiliary diagnosis and medical imaging auxiliary diagnosis.

According to the White Paper, China's healthcare industry is gradually developing from the stage of “informatization (1.0)” to the stage of “intelligentization (3.0)”, and eventually establishing a value-based healthcare system. The healthcare intelligence industry leverages big data, cloud computing, and AI technology capability to empower the medical logic and evidence, and develop applications and solutions whose performance can be precisely and objectively measurable, thereby reducing costs and improving efficiency for the industry players.

According to the White Paper, China’s healthcare intelligence market is expected to grow at a CAGR of 37.4% between 2025 and 2030, and exceed RMB1.1 trillion in 2030. Fred Mao, the Partner and Managing Director of Frost & Sullivan, told reporters that “the future of healthcare intelligence will evolve into a healthcare system that focuses on improving decision-making efficiency, meeting precision needs, and providing high-value traceable services.”

Five essential elements complement each other to promote the intelligent transformation of the healthcare industry

Entering the era of “healthcare intelligentization (3.0)” and leveraging emerging technologies such as AI and big data, the industry is committed to standardizing and structuring healthcare data, solving problems such as data silos, unleashing the value of healthcare big data, improving the efficiency and accuracy of decision making for medical participants and achieving cost reduction and efficiency in all aspects of the healthcare industry.

The White Paper points out that there are five complementary and essential elements of healthcare intelligence. Firstly, the massive, multi-source, traceable, and machine-computable “healthcare big data” portal is the foundation for building healthcare intelligence. Secondly, “cloud computing” provides the basic capabilities for storage, fast processing as well as analysis and mining of big data to ensure privacy and security. Thirdly, “technology capability (AI)” is the engine to realize data processing, analysis, mining, and industrial application implementation. Fourthly, “medical knowledge and scenario-based experience” will serve as a bridge between the data models and the practical applications, in which Medical and AI experts will need to input their expertise and experience to jointly build, optimize and apply these models, and ensure the models’ applicability, accuracy, and interpretability of different scenarios. Finally, the “high-frequency iteration of scenarios and algorithms” can enhance the depth and reliability of algorithm models and the resulting knowledge and insight generated through closed-loop feedback of data, while improving the intelligence, accuracy, and efficiency of applications and solutions.

Healthcare intelligence enables the industry to provide applications and cost reduction and efficiency solutions covering multiple scenarios for the five types of key industry participants. These include public health monitoring and population health management solutions for regulators, and real-world research, safety monitoring, and research solutions for pharmaceutical companies. Looking ahead, healthcare intelligence will empower the healthcare industry to build an efficient, personalized, accurate, accessible, and value-based healthcare system and thereby achieving industrial upgrading.

Yidu Tech leads China’s healthcare intelligence industry with its outstanding competitive advantages

The White Paper compared companies within the China healthcare intelligence industry based on several criterias including expert opinions, AI technical indicators, business coverage, as well as the scope of application and solution implementation. According to the White Paper, Yidu Tech has strong performance in the five essential elements, leading the industry to improve in the areas of cloud computing, big data, AI, medical knowledge, and scenario-based experience, as well as the iteration of scenarios and algorithms.

In terms of "big data" processing capability, the construction of Hainan Real World Data Research Platform Phase I in which the Company has participated in has passed acceptance, facilitating the approvals of new specialty drugs and devices. Meanwhile, the Company has obtained several certificates including the "Certificate of Special Evaluation of Multi-party Secure Computing Foundation Capability" by the China Academy of Information and Communications Technology. The Company possesses 474 patents and software copyrights and has published over 120 papers, fully demonstrating its strengths in "cloud computing" and "AI technology capability". In addition, the Company’s internal talent team covers areas such as algorithm engineering, data science, and clinical medicine, with over 100 number of staff specializing in both technology and medicine. Furthermore, its external expert team includes scholars from Tsinghua University and Peking University, as well as a member of the Disease Prevention and Control Expert Committee of the Ministry of Health, possessing strong "medical knowledge and scenario-based experience". The Company’s business now covers 21 regulatory authorities, 78 top research hospitals, and 17 of the top 20 global pharmaceutical and medical device companies in terms of revenue, and it has implemented and validated its pandemic detection and prediction algorithm in 12 cities, highlighting its capability of "high-frequency iteration of scenario and algorithm".

Based on the above mentioned core competencies, the White Paper stated that in 2021, Yidu Tech outperformed its competitors in terms of the market shares in "China’s healthcare intelligence market" and the "healthcare institutions and regulators segment". The market share of the Company in “China’s emerging healthcare intelligence market” achieved 25.6%, reflecting its leading position in the market.

YiduCore helps accelerate the development of industrial intelligentization

As a leading company in the healthcare intelligence sector, Yidu Tech utilizes YiduCore, the Company’s proprietary healthcare intelligence infrastructure to continuously produce and refine algorithm models and insights, offering intelligent solutions that can be applied in multiple scenarios to healthcare industry participants. Dr. Yan Jun, the Chief Technology Officer and Chief AI Scientist of Yidu Tech, told reporters that “leveraging the healthcare intelligence infrastructure YiduCore, the Company can assist customers such as medical institutions in the efficient and high-quality governance of authorized data, making data computable while continuing to iterate and enhance its algorithms through autonomous learning, as well as continuously accumulating and strengthening modelled knowledge graphs to facilitate breakthroughs in clinical diagnosis and treatment and disease cognition. All of these will help provide value in multiple scenarios such as public health, research and diagnosis, and realize industrial upgrades in the digital economy and intelligent decision making in all parts of the industry chain, which in turn assists the intelligent development of the healthcare industry."

Against the backdrop of China’s aging population and the introduction of national policies that promote the integration of the healthcare industry with cutting-edge technologies, the demand for cost reduction and efficiency improvement from key industry players including healthcare institutions, pharmaceutical, and medical device companies will continue to rise, presenting an enormous development potential in China's healthcare intelligence industry. Yidu Tech will continue to consolidate its technical strengths, deepen and enrich its knowledge and insights in various diseases, further diversify its ecosystem, and create greater value for the stakeholders within the ecosystem through its healthcare intelligence infrastructure, to make value-based precision healthcare accessible to everyone.

- END -

About Yidu Tech Inc.

Founded in 2014, Yidu Tech Inc. ("Yidu Tech", stock code: 2158.HK) has been focusing on the development and application of healthcare intelligence since its inception. The Group focuses on solving the pain points of intelligent applications in the three major healthcare scenarios of public health, research, and diagnosis and treatment, empowering the industry through healthcare intelligence infrastructure, and promoting the construction of a safe, accessible, and value-based healthcare system. In January 2021, Yidu Tech was successfully listed on the Main Board of the Hong Kong Stock Exchange.

Yidu Tech primarily operates in three business segments, namely Big Data Platform and Solutions, Life Sciences Solutions, and Health Management Platform and Solutions, which facilitate medical and clinical research, health management, public health management and development of innovative drugs, as well as assist the industry to reduce cost and improve efficiency, with an aim to make value-based precision healthcare accessible to everyone.